[Ip-health] New Resource on Covid-19 Vaccine Access

Marcela Vieira marcelacfvieira at gmail.com
Tue Feb 23 09:39:58 PST 2021

Dear all,

I believe this new resource by the Global Health Centre, Graduate Institute
of Geneva might be of interest to you.

New Resource on Covid-19 Vaccine Access

COVID-19 Vaccine Purchasing & Manufacturing Arrangements:

The Covid-19 pandemic has driven extraordinary scientific efforts to
develop effective and safe vaccines. With several vaccines being
distributed and dozens of candidates in late-stage development, countries
are concluding purchasing and manufacturing agreements with pharmaceutical
companies to immunise their populations. In order to shed light on which
countries may get access to which vaccine, at what prices and when, the
Global Health Centre recently published an open dataset on Covid-19 vaccine
purchasing and manufacturing arrangements. This new resource tracks and
analyses publicly available data on agreements to manufacture, purchase,
supply and/or donate Covid-19 vaccines.

This resource page offers data on agreements for 16 vaccines (or vaccine
candidates), and 63 countries or territories, the African Union, the
European Union, and COVAX. Many high-income countries have now secured
enough doses to cover their populations twice over, but most other
countries have only secured doses to cover less than 50% of their
populations. Bilateral agreements struck by high income countries have
secured 3.68 doses/capita, while for upper-middle income countries the
figure is 0.47 doses/capita, and lower-middle income countries 0.129
doses/capita. Low-income countries have bilaterally secured only 0.03
doses/capita, however, in recent weeks, some countries have begun to donate
vaccine doses to other countries, either from their purchased stocks or
from domestically produced vaccines. Shipments from COVAX, scheduled to
begin in the coming weeks, are also expected to increase coverage in
recipient countries.

In most cases, there is little transparency on key terms and conditions of
these agreements. For example, price data was only available for one out of
five purchases.

As the situation continues to evolve, the data will be updated and made
publicly-available every 1-2 weeks. Complete the following form to receive
update notifications.

Anna Bezruki is lead Researcher for this resource, with important
contributions from Surabhi Agarwal, Adrian Alonso Ruiz, Marcela Vieira and
Suerie Moon.

Marcela Vieira, LLB, MPH
Researcher and Project Coordinator of the
Knowledge Network for Innovation and Access to Medicines

Global Health Centre, Research
Graduate Institute of International and Development Studies
marcela.vieira at graduateinstitute.ch

More information about the Ip-health mailing list